Second edition

05.qxd 3/10/08 9:34 AM Page 202
202 Syndromes of cognitive impairment
O’Connor JF, Musher DM. Central nervous system involvement in
systemic lupus erythematosus. Arch Neurol 1966; 14:157–64.
O’Hare JA, Callaghan NM, Murnaghan DJ. Dialysis
encephalopathy. Clinical, electroencephalographic, and
interventional aspects. Medicine 1983; 62:129–41.
O’Keefe S, Lavan J. The prognostic significance of delirium in older
hospital patients. J Am Geriatr Soc 1997; 45:174–8.
Oksanen V. Neurosarcoidosis: clinical presentations and course in
50 patients. Acta Neurol Scand 1986; 73:283–90.
Olazaran J, Muniz R, Reisberg B et al. Benefits of cognitive-motor
intervention in mild to moderate Alzheimer’s disease.
Neurology 2004; 63:2348–53.
Oppenheimer BS, Fishberg AM. Hypertensive encephalopathy.
Arch Int Med 1928; 41:264–78.
Palatucci DM. Paradoxical halide levels in bromide intoxication.
Neurology 1978; 28:1189–92.
Palmai G, Taylor DC, Falconer MA. A case of craniopharyngioma
presenting as Korsakoff’s psychosis. Br J Psychiatry 1967;
113:619–23.
Palmini AL, Gloor P, Jones-Gotman M. Pure amnestic seizures in
temporal lobe epilepsy. Brain 1992; 115:749–69.
Palsson A, Thulin SO, Tunving K. Cannabis psychosis in south
Sweden. Acta Psychiatr Scand 1982; 66:311–21.
Pampiglione G, Moynahan EJ. The tuberous sclerosis syndrome:
clinical and EEG studies in 100 children. J Neurol Neurosurg
Psychiatry 1976; 39:666–73.
Papazian O, Canizales E, Alfonso I et al. Reversible dementia and
apparent brain atrophy during valproate therapy. Ann Neurol
1995; 38:687–91.
Park SA, Hahn JH, Kim JI et al. Memory deficits after bilateral
anterior fornix infarction. Neurology 2000; 54:1379–82.
Pascual-Castroviejo I, Diaz-Gonzalez C, Garcia-Melian RM et al.
Sturge–Weber syndrome: study of 40 patients. Pediatr Neurol
1993; 9:283–8.
Paulson GW, Martin EW, Mojzisik C et al. Neurologic
complications of gastric partitioning. Arch Neurol 1985;
42:675–7.
Payton JB, Burkhart JE, Hersen M et al. Treatment of ADDH in
mentally retarded children: a preliminary study. J Am Acad
Child Adolesc Psychiatry 1989; 28:761–7.
Pearlson GD. Psychiatric and medical symptoms associated with
phencyclidine (PCP) abuse. Johns Hopkins Med J 1981;
148:25–33.
Peavy GM, Herzog AG, Rubin NP et al. Neuropsychological aspects
of motor neuron disease: a report of two cases. Neurology
1992; 42:1004–8.
Penfield W, Mathieson G. Memory: autopsy findings and
comments on the role of hippocampus in experiential recall.
Arch Neurol 1974; 31:145–54.
Penfield W, Milner B. Memory deficit produced by bilateral lesions in
the hippocampal zone. Arch Neurol Psychiatry 1958; 79:475–97.
Pepin EP, Auray-Pepin L. Selective dorsolateral frontal lobe
dysfunction associated with diencephalic amnesia. Neurology
1993; 43:733–41.
Perini GI, Colombi G, Armani M et al. Intellectual impairment and
cognitive evoked potentials in myotonic dystrophy. J Nerv
Ment Dis 1989; 177:750–4.
Perren F, Clarke S, Bogousslavsky J. The syndrome of combined
polar and paramedian thalamic infarction. Arch Neurol 2005;
62:1212–16.
Perry JR, Warner E. Transient encephalopathy after paclitaxel
(Taxol) infusion. Neurology 1996; 46:1596–9.
Petermann AF, Hayles AB, Dockerty MB et al. Encephalotrigeminal
angiomatosis (Sturge–Weber disease). Clinical study of thirtyfive
cases. J Am Med Assoc 1958; 167:2169–76.
Petersen RC, Thomas RG, Grundman M et al. Vitamin E and
donepezil for the treatment of mild cognitive impairment. N
Engl J Med 2005; 352:2379–88.
Petersen RC, Parisi JE, Dickson DW et al. Neuropathologic features
of amnestic mild cognitive impairment. Arch Neurol 2006;
63:665–72.
Pflanz S, Besson JAO, Ebmeier KP et al. The clinical manifestations
of mental disorders in Huntington’s disease: a retrospective
case record study of disease progression. Acta Psychiatr Scand
1991; 83:53–60.
Phillips S, Sangalang V, Sterns G. Basal forebrain infarction: a
clinicopathologic corelation. Arch Neurol 1987; 44:1134–8.
Pickering-Brown SM, Richardson AMT, Snowden JS et al. Inherited
frontotemporal dementia in nine British families associated
with intronic mutations in the tau gene. Brain 2002;
125:732–51.
Pierce LB. Pellagra: report of a case. Am J Psychiatry 1924;
81:237–43.
Pincus JH, Reynolds EH, Glaser GH. Subacute combined system
degeneration with folate deficiency. J Am Med Assoc 1972;
221:496–7.
Pittinger C, Desan PH. Gabapentin abuse, and delirium tremens
upon gabapentin withdrawal. J Clin Psychiatry 2007;
68:483–4.
Plum F, Posner JB, Hain RF. Delayed neurological deterioration
after anoxia. Arch Int Med 1962; 110:56–63.
Pompeii P, Foreman M, Rudberg MA et al. Delirium in hospitalized
older persons: outcomes and predictors. J Am Geriatr Soc
1994; 42:809–15.
Pope HG, Keck PE, McElroy SL. Frequency and presentation of
neuroleptic malignant syndrome in a large psychiatric
hospital. Am J Psychiatry 1986; 143:1227–33.
Portet F, Ousset PJ, Visser PJ et al. Mild cognitive impairment in
medical practice: critical review of the concept and new
diagnostic procedure. Report of the MCI working group of the
European Consortium on Alzheimer’s disease (EADC). J Neurol
Neurosurg Psychiatry 2006; 77:714–18.
Postma JU, Van Tilburg W. Visual hallucinations and delirium
during treatment with amantadine (Symmetrel). J Am Geriatr
Soc 1975; 23:212–15.
Potter NT, Meyer MA, Zimmerman AW et al. Molecular and
clinical findings in a family with dentatorubral-pallidoluysian
atrophy. Ann Neurol 1995; 37:273–7.
Powers JM, Schaumburg HH, Gafney CL. Kluver–Bucy syndrome
caused by adrenoleukodystrophy. Neurology 1980;
30:1131–2.
Preskorn SH, Simpson S. Tricyclic-antidepressant-induced delirium
and plasma drug concentration. Am J Psychiatry 1982;
139:822–3.